tACS for Amyloid-β Reduction in Alzheimer's Disease

NCT03290326 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Massachusetts General Hospital